Kymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.
About the role
Kymera Therapeutics is seeking an experienced and strategic Associate Director or Director of Statistical Programming to lead programming efforts for a compound-level program spanning multiple clinical studies. This role will be instrumental in ensuring high-quality, timely, and compliant statistical deliverables in support of Kymera's innovative degrader pipeline. Found on 1752vc Careers, the job board for startup and VC roles.
What they're looking for
- MS or equivalent degree in Statistics, Biostatistics, Computer Science, or a related field (BS with substantial relevant experience will be considered)
- 8+ years of statistical programming experience in the pharmaceutical or biotechnology industry, including experience supporting Phase I, II, and III clinical trials
- Demonstrated leadership of programming activities for a compound-level program, with proven experience influencing across functions
- Proven experience overseeing CROs and external vendors, with accountability for quality, timelines, and deliverables
- Hands-on experience writing SDTM and ADaM specifications and setting up and managing in-house programming workflows and projects, including task allocation, validation, and quality control
- Advanced SAS programming proficiency, with proven ability to independently produce high-quality analysis datasets, tables, listings, and figures, including for ad hoc data requests
More about this role
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn .
- PIONEER : We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines.
- COLLABORATE : We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine.
- BELONG : We recognize our differences, inviting...
Browse similar: Startup jobs